Localization and role of NPC1L1 in cholesterol absorption in human intestine Published, JLR Papers in Press, July 7, 2006.

Recent studies have documented the presence of Niemann-Pick C1-Like 1 (NPC1L1) in the small intestine and its capacity to transport cholesterol in mice and rats. The current investigation was undertaken to explore the localization and function of NPC1L1 in human enterocytes. Cell fractionation experiments revealed an NPC1L1 association with apical membrane of the enterocyte in human jejunum. Signal was also detected in lysosomes, endosomes, and mitochondria. Confirmation of cellular NPC1L1 distribution was obtained by immunocytochemistry. Knockdown of NPC1L1 caused a decline in the ability of Caco-2 cells to capture micellar [14C]free cholesterol. Furthermore, this NPC1L1 suppression resulted in increased and decreased mRNA levels and activity of HMG-CoA reductase, the rate-limiting step in cholesterol synthesis, and of ACAT, the key enzyme in cholesterol esterification, respectively. An increase was also noted in the transcriptional factor sterol-regulatory element binding protein that modulates cholesterol homeostasis. Efforts were devoted to define the impact of NPC1L1 knockdown on other mediators of cholesterol uptake. RT-PCR evidence is presented to show the significant decrease in the levels of scavenger receptor class B type I (SR-BI) with no changes in ABCA1, ABCG5, and cluster determinant 36 in NPC1L1-deficient Caco-2 cells. Together, our data suggest that NPC1L1 contributes to intestinal cholesterol homeostasis and possibly cooperates with SR-BI to mediate cholesterol absorption in humans.

[1]  M. Willingham,et al.  Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface Facilitates Free Cholesterol Uptake* , 2006, Journal of Biological Chemistry.

[2]  Jonathan C. Cohen,et al.  Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Lammert,et al.  New insights into the genetic regulation of intestinal cholesterol absorption. , 2005, Gastroenterology.

[4]  T. Sudhop,et al.  Cholesterol and plant sterol absorption: recent insights. , 2005, The American journal of cardiology.

[5]  Y. Ioannou,et al.  Inactivation of NPC1L1 Causes Multiple Lipid Transport Defects and Protects against Diet-induced Hypercholesterolemia* , 2005, Journal of Biological Chemistry.

[6]  P. Howles,et al.  Molecular mechanisms of cholesterol absorption and transport in the intestine. , 2005, Seminars in cell & developmental biology.

[7]  E. Levy,et al.  Identification of microsomal triglyceride transfer protein in intestinal brush-border membrane. , 2004, Experimental cell research.

[8]  S. Farber,et al.  Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Levy,et al.  Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine , 2004, Journal of Cell Science.

[10]  E. Levy,et al.  Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[11]  E. Levy,et al.  Localization of Microsomal Triglyceride Transfer Protein in the Golgi , 2002, The Journal of Biological Chemistry.

[12]  C. Strader,et al.  The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. , 2002, Biochimica et biophysica acta.

[13]  H. Hauser,et al.  Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine. , 2001, Biochemistry.

[14]  P. Howles,et al.  Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine. , 2001, Journal of lipid research.

[15]  A. Rigotti,et al.  Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. , 2001, Journal of lipid research.

[16]  E. Levy,et al.  Iron-ascorbate alters the efficiency of Caco-2 cells to assemble and secrete lipoproteins. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[17]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Rosenfeld,et al.  Co-stimulation of Promoter for Low Density Lipoprotein Receptor Gene by Sterol Regulatory Element-binding Protein and Sp1 Is Specifically Disrupted by the Yin Yang 1 Protein* , 1999, The Journal of Biological Chemistry.

[19]  F. E. Weber,et al.  Identification of a receptor mediating absorption of dietary cholesterol in the intestine. , 1998, Biochemistry.

[20]  T. Osborne,et al.  Specificity in cholesterol regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Cohen,et al.  Cellular effects of hypercholesterolemia in modulation of cancer growth and metastasis: a review of the evidence. , 1997, Surgical oncology.

[22]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[23]  E. Levy,et al.  Insulin modulation of newly synthesized apolipoproteins B‐100 and B‐48 in human fetal intestine: Gene expression and mRNA editing are not involved , 1996, FEBS letters.

[24]  D. Labuda,et al.  Lipid processing and lipoprotein synthesis by the developing human fetal colon. , 1996, The American journal of physiology.

[25]  P. Edwards,et al.  Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Matthew A. Thomas,et al.  Regulation and Immunolocalization of Acyl-Coenzyme A:Cholesterol Acyltransferase in Mammalian Cells as Studied with Specific Antibodies (*) , 1995, The Journal of Biological Chemistry.

[27]  M. Bendayan.  Colloidal gold post-embedding immunocytochemistry. , 1995, Progress in histochemistry and cytochemistry.

[28]  E. Levy,et al.  Caco‐2 cells as a model for intestinal lipoprotein synthesis and secretion , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  B. Vessby.  Nutrition, lipids and diabetes mellitus. , 1995, Current opinion in lipidology.

[30]  J. Dietschy,et al.  Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver. , 1994, Gastroenterology.

[31]  B. Howard,et al.  Dietary Fats, Insulin Resistance, and Diabetes , 1994, Journal of cardiovascular risk.

[32]  Mojtaba Esfahani,et al.  Advances in Cholesterol Research , 1990 .

[33]  J. R. Smith,et al.  Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. , 1990, The Journal of biological chemistry.

[34]  M. Brown,et al.  Loss of transcriptional repression of three sterol-regulated genes in mutant hamster cells. , 1989, The Journal of biological chemistry.

[35]  D. S. Lin,et al.  The absorption of cholesterol and the sterol balance in the Tarahumara Indians of Mexico fed cholesterol-free and high cholesterol diets. , 1985, The American journal of clinical nutrition.

[36]  F. Field,et al.  Regulation of rabbit intestinal acyl coenzyme A-cholesterol acyltransferase in vivo and in vitro. , 1982, Gastroenterology.

[37]  R. G. Salome,et al.  Effect of dietary fat saturation, cholesterol and cholestyramine on acyl-CoA: cholesterol acyltransferase activity in rabbit intestinal microsomes. , 1982, Biochimica et biophysica acta.

[38]  M. Bendayan,et al.  Double immunocytochemical labeling applying the protein A-gold technique. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  M. Huff.  Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[40]  G. Steiner.  The need for a different cholesterol lowering drug. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

[41]  F. Field,et al.  Intestinal lipoprotein synthesis and secretion. , 1995, Progress in lipid research.

[42]  P. Layer,et al.  Novel functions of cholinesterases in development, physiology and disease. , 1995, Progress in histochemistry and cytochemistry.

[43]  M. Bendayan.  Enzyme-gold electron microscopic cytochemistry: A new affinity approach for the ultrastructural localization of macromolecules , 1984 .

[44]  C. Drevon,et al.  Coenzyme-A-dependent esterification of cholesterol in intestinal mucosa from guinea-pig. Influence of diet on the enzyme activity. , 1977, Scandinavian journal of gastroenterology.

[45]  Luquan Wang,et al.  Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption , 2022 .